Clinical Trial Update: Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

SHPL-49 Injection is being studied in a Phase III trial for acute ischemic stroke and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SHPL-49 Injection (SHPL-49)

Snippet

Sponsor: Shanghai Hutchison Pharmaceuticals Limited | Conditions: Acute Ischemic Stroke | Phase 3 | Status: RECRUITING